Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Venture Funding Deals: I-Mab Is The Mega-Round Leader With $220m Series C

Jul 05 2018

• By Deanna Kamienski, Beth Allan, and Maureen Riordan

Venture Funding Reg column image

Related Content

Venture Funding Deals, June 2015

Jun 04 2015

Finance Watch: Another Mega-Round As Moderna Bucks Biopharma's IPO Trend

Feb 05 2018

iTeos Says Adios To IDO And Eyes US IPO

Jun 20 2018

Learning From Human Cell Hijacking Masters: ENYO Pharma Takes Virus Tricks Into Drug Discovery

Jun 21 2018

Akero Thinks It Will Produce A Next-Wave Therapy For NASH With Former Amgen Compound

Jun 25 2018

Finance Watch: Dementia Discovery Fund Exceeds Fundraising Goal By $150m

Jun 26 2018

£88m Series B For Syncona-backed Freeline To Advance Liver Gene Therapy Focus

Jun 19 2018

Finance Watch: Pfizer Ventures' Dalton Makes Sense Of Neuroscience Focus Within New $600m VC Fund Commitment

Jun 13 2018

Deal Watch: Amazon Moves Into Rx Services With Acquisition Of PillPack

Jul 02 2018

Venture Funding Deals, July – August 2016

Sep 08 2016

Related Companies

AIVITA Biomedical, Inc.

Akero Therapeutics, Inc.

Amgen, Inc.

BridgeBio Pharma, Inc.

BridgeBio Pharma, Inc.

Abliva AB

Carisma Therapeutics Inc.

Decibel Therapeutics, Inc.

Regeneron Pharmaceuticals, Inc.

ENYO Pharma SAS

Infinant Health

Spur Therapeutics Limited

Just – Evotec Biologics

I-Mab

iTeos Therapeutics Inc.

Kaleido Biosciences, Inc.

Metacrine, Inc.

Nimbus Therapeutics, Inc.

NodThera Limited

Selvita S.A.

Precision BioSciences, Inc.

Gilead Sciences, Inc.

Skyhawk Therapeutics, Inc.

Bristol Myers Squibb Company

Vaxcyte, Inc

Zurex Pharma Inc.

Additional Topics

Financing StartUps and SMEs Business Strategies Deals Commercial BioPharmaceutical

More from Financing

More from Business

Twitter feed RSS feed RSS feed

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.